Tuesday, September 22, 2026

$FOUR: Shift4 at 6.5x EBITDA. Is the organic growth real? | Emeth Value Capital

Shift4 trades at 6.5x EBITDA despite 11% reported organic growth, with Shift4 Dine equipment leases cited as evidence of net-new merchant additions.

FOUR $2.9B

Yet Another Value Podcast Sep 22 21 clicks

Sep 22 VSH $5.8B

Analog Semiconductor Smorgasbord, Feat. TXN, ON, VSH

Cestrian Capital Research 6 clicks

Sep 22 FLY $3.9B

Monte Investments Market Brief Vol. CXXVIII

Monte Independent Investment Research 9 clicks

From X

@BarbarianCap Sep 22

Barbarian Capital on X

KB Home Cuts Margin Outlook as Housing Conditions Worsen $KBH https://t.co/OA4utledZC

@BarbarianCap Sep 22 1 click

Barbarian Capital on X

$FUN Activist Jana Partners Urges Six Flags to Explore Sale https://t.co/ifMKt79541

@finphysnerd Sep 22 3 clicks

Myles on X

@HatfieldCapital @RealHerbHoover From what I've read $MMS has some exposure to va healthcare repricing as well. More importantly the rest of the business is lower quality. No defence/intelligence exposure, some segments overearning (natural disaster work and soft services volumes). Still looks cheap.

@BrokenMoats Sep 22 7 clicks

Broken Moats on X

Anyone have any suggestions how Muse and Grokbot and more versions to come of agent personal assistants is bullish of communication stocks like $RNG and $FIVN? Took out some of the intermediary businesses like $EVER and some pressure on $EXPE earlier in the day but seems next level is EXPE, some of the insurance brokers, and then phone communication systems seem at the top of losers from changing engagement and channels for B2C and B2B comms

@IdeaBrunchEmail Sep 22 4 clicks

Idea Brunch on X

Idea Brunch with David Polansky and Tim Delaney of Immersion Investments David and Tim break down their small-cap-focused research process and share commentary on $MAMA $SRTA and $RDVT Enjoy! https://t.co/zWh7qAOCoO

@P_Remarks Sep 22 3 clicks

Prepared Remarks on X

$MTCH bull case https://t.co/8iJYHVs7dl

@KEDM_COM Sep 22 1 click

KEDM.com on X

Fitlife $FTLF insiders are buying the dip. The shares are down over 50% over the past few months, mainly on poor earnings. But taking a step back, Fitlife has been executing on its strategy. Good, accretive acquisitions, decent organic growth, and a continued push to online. https://t.co/NeblRc2KhF

@TheBenSchmark Sep 22

JabroniCoin.USD on X

SocGen really seems like the Citi of Europe. $GLE $C AI-driven cost reduction, and ROTE acceleration? Or is the CH Robinson of banks? https://t.co/gNqcJVvRFc https://t.co/ui4wQ2uf8Z

Cellebrite (CLBT) Management Meeting: The Road Ahead

Cellebrite converts more than 110% of EBITDA into free cash flow and trades at 12.5 times free cash flow, with management targeting 15% or…

CLBT $2.8B

Aurelion Research Sep 22 9 clicks

Meta's Muse Could be Big Win for Innodata

Innodata's new Meta contract for long-horizon agent personalization ties the data company to Meta's Muse AI assistant, despite Meta's Scale…

INOD $2.4B

Hunterbrook Sep 22 12 clicks

Undercovered Dozen: Rithm Capital, Sterling Infrastructure, Corning And More

Undercovered Dozen spotlights 12 lesser-covered stocks, including Rithm Capital, Sterling Infrastructure and Corning.

RITM $5B

The Undercovered Dozen Sep 22

Emeth Value Capital’s Andrew Carreon on Shift4 ($FOUR)

Shift4 trades at 6.5 times EBITDA despite 11% organic growth, with Shift4 Dine equipment leases reaching a $400 million run rate as…

FOUR $2.9B

Yet Another Value Blog Sep 22 4 clicks

Copart's Return To Growth Starts Now: Adair's $1.9B Bet On ACV Auctions

Copart’s $1.9 billion ACV Auctions acquisition targets renewed growth, with EPS accretion expected by fiscal 2028 as insurance…

ACVA $1.8B

Robert J. Lake Sep 22 2 clicks

Quick Value #331 - Corteva / Vylor Spin-Off

Corteva will spin off its Pioneer seed business, Vylor, on October 1, leaving crop protection RemainCo that could trade at 6.5-8.5x 2026…

CTVA $8.4B

Value Don't Lie Sep 21 5 clicks

[CoStar] Homes are different

CoStar spent more than $1 billion building Homes.com to challenge Zillow, betting seller-agent leads, proprietary listing content and…

ZG $6.2B

scuttleblurb Sep 21 4 clicks

ARKO. 3x Owner’s Earnings multiple, 21% ROCE, Founders involved and large shareholders, Stake in a public company>market cap. Superb Capital Allocators

ARKO trades at 3 times estimated 2025 owner’s earnings, while its 73.6% APC stake exceeds its $473 million market cap.

ARKO $453M

Calvin Blissett Sep 21 4 clicks

Bioventus: Cash Flow Anchors The Bull Case Beyond A Potential Sale

Bioventus uses established-product cash flow to cut debt and fund launches, while its 2030 term loan extension and lower margin support its…

BVS $1.1B

Equity Eagle Sep 21

I Tested Three Cannibals Against Dillard’s. I Bought Two. (CROX, CNX, GPI)

Crocs, CNX and Group 1 are tested against Dillard’s buyback-driven share-count reduction, with Group 1 leading and CNX’s convertible notes…

CROX $5.7BCNX $4.7B

Cannibal Stocks Sep 20 2 clicks

HNRG · long

Hallador Energy CO

Hallador Energy, a coal producer, is pitched as a long based on five value components and potential 2026 catalysts.

HNRG $644M

Value Investors Club Jun 15 3 clicks

Atlas Engineered Products ($AEP.V) FINS Review

Atlas Engineered Products reported Q2 revenue up 19% to $16.2 million, but ended cashless on its credit line as inventory rose 47% and…

APEUF $30M

Wolf's Substack Aug 25 10 clicks

Monte Investments Market Brief Vol. CXXV

Nvidia reports Q2 2027 earnings August 26, with data-center backlogs, enterprise AI inference demand and Vera Rubin volume sales expected…

ONDS $4.3B

Monte Independent Investment Research Aug 25

US-Canada Tariffs: Finding Investment Opportunities

US-Canada tariffs impose 50% duties on $20 billion of Canadian goods, lifting US steel makers while pressuring Canadian exporters and…

ASTL $450M

Aurelion Research Aug 24

NRIX 2026-08-24

Nurix Therapeutics: Roche Has Changed The Economics Of The Bull Case

Nurix Therapeutics gained $700 million upfront from Roche, a 50% U.S. profit share and Roche-funded global bexobrutideg development,…

NRIX $2.5B

Equity Eagle Aug 24 3 clicks

CDTi Advances Multi-Sector Catalyst Programs as Blue-Chip Partners Near Production

CDTi has doubled revenue since 2020 to $10 million and is moving catalyst programs for data centers, methane abatement and carbon capture…

CDTI $9.4M

Byron Street Research Aug 24

The Junk (Mail) Merger Arb

Star Equity’s $5 per-share Harte-Hanks acquisition offers $2.50 cash plus 0.25 STRRP per share after proration, against a $2 break price.

STRR $36MHHS $34M

Triple S Special Situations Investing Aug 24 8 clicks

RCEL 2026-08-24

AVITA Medical: Favorable Reimbursements For Skin Wound Care

AVITA Medical’s more predictable reimbursement, RECELL GO rollout and PermeaDerm economics support adoption, with cash flow breakeven…

RCEL $363M

Myriam Alvarez Aug 24 4 clicks

Portillo’s: Strategic Reset

Portillo’s reset follows weak Texas unit economics, cutting next year’s openings to five from roughly 10 annually and shrinking store…

PTLO $272M

TSOH Investment Research Aug 24

UEC 2026-08-24

Uranium Energy Ranks High Among The Bravest Companies I Ever Covered

Uranium Energy Corp. is withholding production at low uranium prices while funding mine development through future share issuance.

UEC $4.6B

Marc Gerstein Aug 24 3 clicks

Tuesday, September 22, 2026

Barbarian Capital on X

Barbarian Capital on X

Myles on X

Broken Moats on X

Idea Brunch on X

Prepared Remarks on X

KEDM.com on X

JabroniCoin.USD on X

Investor Letters

Publications we follow

Newsletters 93

YouTube 4

Blogs 12

Seeking Alpha 41 of 198

X accounts we follow

Investor letters we follow

Sectors